Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_731a5c14521f8abac80caa8a90045c83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2064e45965e17eff1cfe75ea2667c809 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2009-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd5b2c1b6d366da4fb8a9d20268b954 |
publicationDate |
2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011042623-A |
titleOfInvention |
junB gene expression promoter |
abstract |
The present invention provides a novel junB gene expression promoter that is expected to be applied as a carcinogenesis inhibitor. A compound selected from glycyrrhizin and a pharmaceutically acceptable salt thereof is used as a component of a junB gene expression promoter. [Selection] Figure 1 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013190537-A |
priorityDate |
2009-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |